Author: He, Jiayang; Li, Zhengtu; Huang, Wanyi; Guan, Wenda; Ma, Hongxia; Yang, Zi feng; Wang, Xinhua
Title: Efficacy and safety of Chou-Ling-Dan granules in the treatment of seasonal influenza via combining Western and traditional Chinese medicine: protocol for a multicentre, randomised controlled clinical trial Document date: 2019_4_2
ID: vn9e5nm3_7
Snippet: iii. Per-protocol population (PPP) 386 The PPP is all cases includes those cases that meet the inclusion criteria, are in full accordance iv. Safety analysis population (SAP) 391 After randomisation, the study drug is taken at least once and after intervention, effective 392 safety evaluation data has been recorded at least once. 393 In this experiment, the baseline data and efficacy analysis will be analysed by the MITTP. 394 Simultaneously, the.....
Document: iii. Per-protocol population (PPP) 386 The PPP is all cases includes those cases that meet the inclusion criteria, are in full accordance iv. Safety analysis population (SAP) 391 After randomisation, the study drug is taken at least once and after intervention, effective 392 safety evaluation data has been recorded at least once. 393 In this experiment, the baseline data and efficacy analysis will be analysed by the MITTP. 394 Simultaneously, the primary efficacy endpoint will have PPP analysis, but the conclusions will be 395 mainly based on MITT analysis. If the results of the MITTP analysis and PPP analysis are 396 consistent, the credibility of the conclusions is increased. If there are missing data, the last 397 observation carry-forward (LOCF) method will be used to extrapolate the data.
Search related documents:
Co phrase search for related documents- analysis population and MITT analysis: 1
Co phrase search for related documents, hyperlinks ordered by date